RE: Update20 Nov 2025 11:00
Roger, your caution is noted — but let’s not confuse prudent skepticism with selective blindness.
Jackson Labs didn’t just verify the data; they validated the biological impact. That’s not a polite nod, it’s a scientific endorsement. If Tim’s interpretation is bold, good — we’re not here for lukewarm leadership. You say “game-changing” is just enthusiasm? Fine. But when the data itself shifts paradigms, maybe enthusiasm is the correct emotional response.
As for the data room — it’s open, yes. But partners don’t knock on doors for sport. They enter when they see value. Silence doesn’t mean absence; it means confidentiality. You want t’s crossed and i’s dotted? So do we. But deals aren’t forged in public forums — they’re sealed behind NDAs, not on LSE chatboards.
And your MM theory — poetic, but let’s not romanticize market mechanics. Forward selling isn’t “oiling the wheels,” it’s often just grease on the palms. If AIM’s survival depends on that kind of collusion, then the real risk isn’t Tim’s optimism — it’s the ecosystem you’re defending.
Let’s not bail before the bell. Tim said end of year. Let’s hold him to it — but let’s not pretend inertia is proof of failure.
OSD - Sticking with Halfbutts advent calender